Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients

BACKGROUND. Type 2 diabetes mellitus (T2DM) is prevalent in patients undergoing heart transplant, and in those without preexisting T2DM, posttransplant diabetes mellitus may develop. Both T2DM and posttransplant diabetes mellitus have been associated with increased morbidity and mortality following...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transplant Direct
Main Authors: Cehic, Matthew G., Muir, Christopher A., Greenfield, Jerry R., Hayward, Christopher, Jabbour, Andrew, Keogh, Anne, Kotlyar, Eugene, Muthiah, Kavitha, Macdonald, Peter S.
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2019
Assuntos:
Heart Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6511439/
https://ncbi.nlm.nih.gov/pubmed/31165085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000885
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados